Organisation paid for research Program year 2025 Source: CMS Open Payments

Biosolutions Clinical Research

Neither a doctor nor a teaching hospital

Research payments

$15,692

7 payments

Through program year 2025, Biosolutions Clinical Research is reported as receiving $15,692 in research payments, across 7 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2025	Research	$15,500	3
2019	Research	$192	4

Breakdown

Who paid Research payments · program years 2019–2025

Takeda Pharmaceuticals U.S.A., Inc. $15,500 3 payments
Pfizer Inc. $192 4 payments

Studies the money was for Research payments · program years 2019–2025

A Multi-Center, Randomized, Double-Blind, Placebo- and Active-Controlled Phase 3 Study to Evaluate the Efficacy and Safety of Zasocitinib (TAK-279) in Subjects With Active Psoriatic Arthritis Who Are Naive to Biologic Disease-Modifying Antirheumatic Drugs (LATITUDE-PsA-3001) $15,500 3 payments
A Phase 3 Randomized Doubleblind Activecontrolled Multicenter Study of the Longterm Safety and Efficacy of Subcutaneous Administration of Tanezumab in Subjects With Osteoarthritis of the Hip Or Knee $192 4 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.